Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1622-4. doi: 10.1007/s00259-013-2501-0. Epub 2013 Jul 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • India
  • Octreotide / analogs & derivatives*
  • Octreotide / economics
  • Octreotide / supply & distribution
  • Octreotide / therapeutic use
  • Organotechnetium Compounds / economics
  • Organotechnetium Compounds / supply & distribution
  • Organotechnetium Compounds / therapeutic use*
  • Radiopharmaceuticals / economics
  • Radiopharmaceuticals / supply & distribution
  • Radiopharmaceuticals / therapeutic use*
  • Reagent Kits, Diagnostic*
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Reagent Kits, Diagnostic
  • technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotide
  • Octreotide